| ²é¿´: 1394 | »Ø¸´: 0 | ||||
liuyijin01гæ (³õÈëÎÄ̳)
|
[½»Á÷]
ÄÏ¿ª´óѧ ҩѧԺ Ò©ÎﻯѧÉúÎïѧȫ¹úÖØµãʵÑéÊÒ ÁõÒÕ½õ ÕÐ2025ÄêÉêÇ뿼ºËÖÆ²©Ê¿1-2Ãû
|
|
ÁõÒÕ½õ£º https://pharmacy.nankai.edu.cn/info/1011/1301.htm ɽ¶«Ê¦·¶´óѧ ÎïÀíϵ ѧʿ£¨1999-2003£© Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿Ëù ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ ²©Ê¿£¨2003-2008£© £¨µ¼Ê¦£ºÈÄ×ÓºÍ ÔºÊ¿£© Ó¢¹ú°©Ö¢Ñо¿ÖÐÐÄÖйúѧÕ߼ƻ®£¨2008-2011£© £¨Cancer Research UK China Fellow Program£© Ó¢¹úµËµÏ´óѧºËËá½á¹¹Ñо¿ÍÅ¶Ó Associate£¨2011-2015£© £¨Nucleic Acid Structure Research Group£¬Ó¢¹ú»Ê¼Ò¿ÆÑ§ÔºDavid Lilley ԺʿÍŶӣ© Ó¢¹úµËµÏ´óѧºËËá½á¹¹Ñо¿ÍŶÓSenior Associate (2015-2018) ÄÏ¿ª´óѧ Ò©ÎﻯѧÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒ ÌØÆ¸Ñо¿Ô±£¬ ҩѧԺ ˫Ƹ½ÌÊÚ ²©Ê¿Éúµ¼Ê¦ (2018- ) ÁõÒÕ½õ ¿ÎÌâ×é ³¤ÆÚ´ÓÊÂÓйؾßÓд߻¯¹¦ÄܵÄÌØÊâRNA·Ö×Ó¡ªºËø( ribozyme) µÄ·Ö×ӽṹ¡¢´ß»¯»úÀíÒÔ¼°»ùÓÚRNAºËø·Ö×ӵİÐÏòÄ¿±êRNAµÄÒ©ÎïÉè¼Æ¹¤×÷¡£ÆäËûÑо¿·½Ïò°üÀ¨Ó«¹âС·Ö×ÓÔÚÑо¿RNA·Ö×ÓµÄʾ×ÙÕÛµþ¹ý³ÌÖеÄÓ¦Ó㬾ßÓÐÖØÒªÒâÒåµÄºËËáøµÄ½á¹¹ÒÔ¼°´ß»¯»úÀí¡£Ñо¿ÊÖ·¨°üÀ¨½á¹¹ÉúÎïѧ£¨¾§Ìåѧ¡¢Àä¶³µç¾µ£©¡¢Éú»¯Óë·Ö×ÓÉúÎïѧ¡¢»¯Ñ§ºÏ³É¡¢µ¥·Ö×ÓÓ«¹â¼°Ï¸°ûÉúÎïѧ¡¢Ð¡ÊóÌåÄÚʵÑéµÈÏà¹Ø¼¼Êõ¡£×î½ü1-2Äê¿ÎÌâ×éͬѧ·¢±í Nature Communications£¬ JACS µÈÂÛÎÄ8ƪ(µ×²¿½üÁ½ÄêÂÛÎÄÁбí)£¬ÁíÓÐ¶àÆª¶¥¿¯ÔÚͶ¡£ Ò»¡¢½üÆÚÑо¿·½Ïò£º 1. Óд߻¯¹¦ÄܵÄÌØÊâRNA·Ö×ӵĽṹºÍ´ß»¯»úÀí 2. СºËËáÒ©Î↑·¢¡¢ºËËá̽ÕëÉè¼Æ£»ÄÉÃײÄÁÏRNA°ÐÏòÒ©ÎïµÝËÍ 3. Ó«¹âС·Ö×ÓÔÚÑо¿RNA½á¹¹ÌØÕ÷¹ý³ÌÖеÄÓ¦Óà 4. µ°°×ºËËḴºÏÎïµÄ½á¹¹ºÍ¹¦ÄÜ ¶þ¡¢ÕÐÊÕ¸Úλ£º ²©Ê¿Ñо¿Éú£º2025Äê ÉêÇ뿼ºËÖÆ²©Ê¿ 1-2ÈË £¨4ÄêÑ§ÖÆ£©¡£ ±¾ÊµÑéÊÒÑо¿·½·¨¹ã·º£¬ÉúÎïѧ¡¢»¯Ñ§¡¢ÎïÀíѧ¡¢²ÄÁÏ¿ÆÑ§µÈ½»²æÈںϣ¬¶Ô²©Ê¿ÉúµÄרҵ±³¾°²»×öÏÞÖÆ¡£Ìṩ²Î»á¡¢³ö·Ã»ú»áÖ§³Ö·¢Õ¹£¬³¤ÆÚÓë¹ãÖÝ£¨¹ú¼Ò£©ÊµÑéÊÒ¡¢ÁªºÏ¹ú¹ú¼Ê»ú¹¹¡¢Ó¢¹ú°©Ö¢Ñо¿ÖÐÐÄ¡¢Ó¢¹úµËµÏ´óѧµÈ»¥·Ã¡£ ÄÏ¿ª´óѧ¶Ô²©Ê¿µÄ´ýÓöÓźñ£¬Èëѧ½±Ñ§½ð1ÍòÔªÒÔÉÏ£¬Ã¿ÔÂÖúѧ½ð¸÷¸öÄê¼¶3000-4000Ôª²»µÈ£¬×¡ËÞÌõ¼þËæ»ú·ÖÅäµ¥¼ä¡¢»òÁ½ÈË¼ä´ø¶ÀÁ¢ÎÀÉú¼äÔ¡ÊҺ͹²Óóø·¿¡£ ¾ßÌåÒªÇóÈçÏ£º 1. Ó¢Óï³É¼¨·ûºÏѧУµÄ¹æ¶¨£¬Í¨¹ýÁù¼¶²âÊÔ£¬»ò¾ßÓÐÏàͬÍâÓïѧÁ¦³É¼¨£»Í¬Ê±¾ßÓнϺõÄÓ¢ÎĶÁдÄÜÁ¦¡£ 2. ÓÐÇ¿ÁҵĶÁ²©ÉîÔìÒâÔ¸£¬Õäϧ»ú»á£¬Ì¤Êµ¿Ï¸É£¬ÔðÈÎÐÄÇ¿£¬¾ßÓÐÍŶӾ«ÉñÒÔ¼°Í¶ÈëµÄ̬¶È¡£ 3. ÒÔµÚÒ»×÷Õߣ¨»òÓÐÍ»³ö¹±Ï׵Ĺ²Í¬Ò»×÷£©·¢±í¹ýSCIÂÛÎÄ£¨»òÂÛÎÄÒѽÓÊÕ£©¡£»òÕßÓгä·ÖµÄÒÀ¾ÝÖ¤Ã÷ÓжÀÁ¢Íê³ÉÑо¿ÏîÄ¿µ½×«¸åͶ¸åµÄ¾Àú¡£ ±¾Äê¶ÈÕÐÉúÖØµã¹Ø×¢¾ß±¸ÒÔÏÂ1-2µã³¤´¦µÄͬѧ£º 1. ÊìϤºËËá̽ÕëÉè¼Æ¡¢ºËËá°ÐÏòµÝËÍÔØÌ壨°üÀ¨µ«²»ÏÞÓÚDNAÔØÌå¡¢Ö¬ÖÊÌåÔØÌå¡¢¶à¾ÛÎïÔØÌåµÈ£© 2. ÊìϤÉúÎï´ó·Ö×Ó¾§Ìå½á¹¹½âÎö»òÕßÀä¶³µç×ÓÏÔ΢¾µÊý¾Ý´¦ÀíºÍ½á¹¹½âÎö¡£ 3. ±¾¿ÆÎªÉúÎï¿ÆÑ§»òÉúÎï¼¼Êõרҵ±³¾°£¬Í¬Ê±¾ßÓÐÍ»³öµÄÓ¢ÎĶÁдÄÜÁ¦¡£ 4. ¾«Í¨ÉúÎïÐÅϢѧͬʱ¾ßÓÐÒ»¶¨ÊµÑéÄÜÁ¦¡£ Èý¡¢ÉêÇë²ÄÁÏ ¸öÈ˼òÀú£º£¨º¬¸öÈË»ù±¾Çé¿ö¡¢Ñ§Ï°¾Àú¡¢¹¤×÷¾Àú¡¢·¢±íÎÄÕÂ ÍÆ¼öÈËÐÕÃûÒÔ¼°ÁªÏµ·½Ê½£©·¢Ë͵½ÓÊÏ䣺y.v.liu@dundee.ac.uk ²¢³ËÍribozyme_lab@foxmail.com ÒÔÈ·±£½ÓÊÕ¡£ ˵Ã÷£º 1. ÕæÊµÃû¶î£¬²»ÐéÕУ¬²»·Å¸ë×Ó¡£ 2. È¥Äêµ×ÖÁ½ñÓв»ÉÙͬѧÌáǰÁªÏµ¹ý£¬ÓÉÓÚµ±Ê±Ãû¶îûÓÐÈ·¶¨£¬Ò»ÂÉûÓлØÐÅ¡£Èç¹ûÓÐÔø¾ÁªÏµ¹ýÎÒµÄͬѧ»¶Ó¸üмòÀúÖØÐ±¨Ãû¡£ 3. ±¨Ãûʱ¼ä½ôÆÈ£¬½öÏÞÓгÏÒâͬѧÁªÏµ£¬ÒÑÓÐofferµÄͬѧ½¨ÒéÕäϧÏÖÓлú»á¡£ 1: Fan C, Zhan X, Guo F, Li Q, Lu K, Shan X, Zhou Y, Ren M, Greenberg MM, Liu Y, Zhou C. Uridine Embedded within DNA is Repaired by Uracil DNA Glycosylase via a Mechanism Distinct from That of Ribonuclease H2. J Am Chem Soc. 2025 Apr 2;147(13):11574-11583. doi: 10.1021/jacs.5c01436. Epub 2025 Mar 25. PMID: 40130361. 2: Zhang J, Zhao M, Xi Z, Liu X, Feng L, Bai J, Zhan X, Zhang C, Midgley AC, Liu Y. Pistol Ribozyme-Driven Catalytic Spherical Nucleic Acid Integrates Gene and Chemotherapy for Enhanced Cancer Therapy. J Am Chem Soc. 2025 Mar 19;147(11):9424-9440. doi: 10.1021/jacs.4c16613. Epub 2025 Mar 10. PMID: 40063899. 3: Lu M, Cao Z, Xiong L, Deng H, Ma K, Liu N, Qin Y, Chen SB, Chen JH, Li Y, Liu Y, Yu Z. A hammerhead ribozyme selects mechanically stable conformations for catalysis against viral RNA. Commun Biol. 2025 Feb 3;8(1):165. doi: 10.1038/s42003-025-07600-3. PMID: 39900966; PMCID: PMC11791167. 4: Zhan X, Wilson TJ, Li Z, Zhang J, Yang Y, Lilley DMJ, Liu Y. The structure and catalytic mechanism of a pseudoknot-containing hammerhead ribozyme. Nat Commun. 2024 Aug 5;15(1):6628. doi: 10.1038/s41467-024-50892-y. PMID: 39103372; PMCID: PMC11300833. 5: Jia X, Tian J, Fu Y, Wang Y, Yang Y, Zhang M, Yang C, Liu Y. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC. Int J Mol Sci. 2024 Apr 16;25(8):4372. doi: 10.3390/ijms25084372. PMID: 38673957; PMCID: PMC11050640. 6: Jia X, Wang Y, Yang Y, Fu Y, Liu Y. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC. Int J Mol Sci. 2023 Dec 18;24(24):17626. doi: 10.3390/ijms242417626. PMID: 38139458; PMCID: PMC10744246. 7: Yang L, Jia X, Fu Y, Tian J, Liu Y, Lin J. Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma. Int J Mol Sci. 2023 Jun 10;24(12):9987. doi: 10.3390/ijms24129987. PMID: 37373132; PMCID: PMC10298112. 8: Gao F, Wu J, Gao H, Hu X, Liu L, Midgley AC, Liu Q, Sun Z, Liu Y, Ding D, Wang Y, Kong D, Huang X. Hypoxia-tropic nanozymes as oxygen generators for tumor-favoring theranostics. Biomaterials. 2020 Feb;230:119635. doi: 10.1016/j.biomaterials.2019.119635. Epub 2019 Nov 18. PMID: 31767443. |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
8475. |
» ²ÂÄãϲ»¶
307Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
288Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ14È˻ظ´
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ18È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
296Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0703»¯Ñ§µ÷¼Á
ÒѾÓÐ13È˻ظ´
085600²ÄÁÏÓ뻯¹¤ Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
ÉúÎïѧµ÷¼ÁÕÐÈË£¡£¡£¡
ÒѾÓÐ4È˻ظ´













»Ø¸´´ËÂ¥


